Haisco Pharmaceutical Group Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Haisco Pharmaceutical Group Co Ltd with three other
companies in this sector in China:
Shanghai Kaibao Pharmaceutical Company Limited
sales of 1.50 billion Chinese Renmimbi [US$221.14 million]
of which 100%
Guilin Sanjin Pharmaceutical Co Ltd
(1.53 billion Chinese Renmimbi [US$225.29 million]
of which 94%
was Proprietary Chinese medicine), and
Jinhe Biotechnology Co Ltd
(1.50 billion Chinese Renmimbi [US$220.87 million]
of which 72%
was Medical Feeds Additives).
During the year ended December of 2016, sales at
Haisco Pharmaceutical Group Co Ltd were 1.44 billion Chinese Renmimbi (US$212.05 million).
increase of 18.4%
versus 2015, when the company's sales were 1.21 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Haisco Pharmaceutical Group Co Ltd
(and since 2011, sales have increased a total of 138%).
Sales of Pharmacy saw an increase
18.4% in 2016, from
1.21 billion Chinese Renmimbi to 1.44 billion Chinese Renmimbi.
Not all segments of Haisco Pharmaceutical Group Co Ltd experienced an increase in sales in 2016:
sales of Other Operating fell 20.1% to 532,017.10 Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).